Literature DB >> 25277779

Congenital factor V deficiency: comparison of the severity of clinical presentations among patients with rare bleeding disorders.

Majid Naderi1, Shadi Tabibian, Shaban Alizadeh, Soudabeh Hosseini, Farhad Zaker, Taregh Bamedi, Morteza Shamsizadeh, Akbar Dorgalaleh.   

Abstract

BACKGROUND: Factor V deficiency (FVD) is a rare bleeding disorder (RBD) mostly present in regions with a high rate of consanguinity. FVD after FXIII deficiency is the next more prevalent RBD in Sistan and Baluchistan (S&B) in southeastern Iran. The aim of this study was to evaluate the clinical manifestations and severity of bleeding diathesis in patients with FVD.
METHODS: This descriptive study was conducted on 23 patients with FVD in S&B province. FVD was diagnosed by clinical findings and routine laboratory tests. Bleeding diatheses were classified into three grades (I-III) depending on the severity of symptoms. The severity of bleeding episodes in our patients was compared with other RBDs. RESULT: Based on residual plasma FV activity, 6 (26%), 16 (69.5%) and 1 (4.5%) patients had mild, moderate and severe factor deficiency, respectively. 24% of the patients had grade III life-threatening bleeding episodes which in comparison with FVII deficiency (17.4%) and FI deficiency (21%) had a higher incidence, and in comparison with FX deficiency (41.7%) and FXIII deficiency (63.1) had a lower incidence. Grade II and grade I bleeding diathesis were observed in 56.2 and 16.7% of the patients, respectively.
CONCLUSION: FVD is the second most common type of RBD in S&B province and grade II bleeding episodes were the major bleeding presentation and observed in more than half of the patients.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 25277779     DOI: 10.1159/000363598

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  7 in total

1.  Miscarriage and recurrent miscarriage in patients with congenital factor V deficiency: a report of six cases in Iran.

Authors:  Majid Naderi; Shadi Tabibian; Morteza Shamsizadeh; Akbar Dorgalaleh
Journal:  Int J Hematol       Date:  2016-03-15       Impact factor: 2.490

2.  Factor V deficiency with a unique genetic mutation presenting as post-circumcision bleeding in a neonate, A-case-report.

Authors:  Fajr M A Sarhan; Ameer Al-Jasim; Raghad H M Alwahsh; Islam I A Mansour
Journal:  Ann Med Surg (Lond)       Date:  2022-05-05

Review 3.  Transfusion in Neonatal Patients: Review of Evidence-Based Guidelines.

Authors:  Patricia E Zerra; Cassandra D Josephson
Journal:  Clin Lab Med       Date:  2020-12-23       Impact factor: 2.172

4.  Rare Diseases with Periodontal Manifestations.

Authors:  Marcel Hanisch; Thomas Hoffmann; Lauren Bohner; Lale Hanisch; Korbinian Benz; Johannes Kleinheinz; Jochen Jackowski
Journal:  Int J Environ Res Public Health       Date:  2019-03-09       Impact factor: 3.390

5.  Standardization of Coagulation Factor V Reference Intervals, Prothrombin Time, and Activated Partial Thromboplastin Time in Mice for Use in Factor V Deficiency Pathological Models.

Authors:  Juan A De Pablo-Moreno; Antonio Liras; Luis Revuelta
Journal:  Front Vet Sci       Date:  2022-03-28

Review 6.  The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V.

Authors:  Juan A De Pablo-Moreno; Luis Javier Serrano; Luis Revuelta; María José Sánchez; Antonio Liras
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

7.  Screening platelet function in blood donors.

Authors:  Pascal Pedini; Jean-Baptiste Baudey; Katia Pouymayou; Celine Falaise; Manal Ibrahim-Kosta; Melanie Vélier; Clémence Demerle; Hajer Graiet; Catherine Dragutini; Anne-Marie Dombey; Jacques Chiaroni; Marie Christine Alessi; Christophe Picard
Journal:  Transfusion       Date:  2022-06-24       Impact factor: 3.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.